| 2017 |
STUB1, a chaperone-dependent E3 ubiquitin ligase, preferentially interacts with and ubiquitinates phosphorylated (inactive) TFEB, targeting it for proteasomal degradation. STUB1 deficiency leads to accumulation of phosphorylated TFEB and reduced TFEB transcriptional activity, reduced autophagy, and reduced mitochondrial biogenesis. |
Immunoprecipitation, immunoblot, STUB1 knockout cells and STUB1-deficient mice, overexpression studies |
The EMBO journal |
High |
28754656
|
| 2013 |
STUB1 is required for degradation of HIF1A by chaperone-mediated autophagy (CMA). STUB1 mutations that abolish either E3 ubiquitin ligase activity or HSPA8-binding prevent HIF1A lysosomal degradation. STUB1 functions downstream of HSPA8 and the CMA receptor LAMP2A to mediate HIF1A ubiquitination and translocation into lysosomes. |
Mutagenesis of STUB1 (ligase-dead and HSPA8-binding mutants), lysosome isolation/translocation assay, immunoprecipitation, immunoblot |
Autophagy |
High |
23880665
|
| 2014 |
STUB1 interacts with IL-4Rα and targets it for ubiquitination-mediated proteasomal degradation, terminating IL-4/IL-13 signaling. STUB1 knockout cells show increased IL-4Rα levels and sustained STAT6 activation; STUB1-deficient mice exhibit spontaneous airway inflammation, M2 macrophage activation, and elevated serum IgE. |
Co-immunoprecipitation, immunoblot, flow cytometry, STUB1 KO mouse model, in vivo lung inflammation measurements |
American journal of respiratory and critical care medicine |
High |
24251647
|
| 2013 |
CHIP/STUB1 negatively regulates NF-κB signaling in colorectal cancer cells by promoting ubiquitination and proteasomal degradation of p65, a NF-κB subunit, leading to decreased expression of NF-κB target oncogenes (Cyclin D1, c-Myc, MMP-2, VEGF, IL-8). |
Overexpression and RNAi knockdown in HCT-116 cells, ubiquitination assay, nude mouse tumor growth assay, immunoblot |
Carcinogenesis |
Medium |
24302614
|
| 2017 |
CHIP/STUB1 (U-box E3 ligase) suppresses the Warburg effect in ovarian carcinoma by interacting with and mediating ubiquitin-proteasomal degradation of pyruvate kinase isoenzyme M2 (PKM2), thereby regulating glycolytic metabolism. |
SiLAD proteomics, Co-IP, ubiquitination assay, CHIP KO MEF cells, in vitro and in vivo tumor growth assays |
Oncogene |
High |
28346425
|
| 2020 |
STUB1 specifically ubiquitinates purified human proteasomes in vitro, mainly via Lys63-linked chains. Inhibited proteasomes are sequestered into aggresomes via HDAC6- and dynein-mediated transport and cleared through selective macroautophagy (proteaphagy); STUB1 activity is required for this proteasome quality-control pathway. |
In vitro ubiquitination assay with purified proteasomes, genetic and chemical inhibition of STUB1, live imaging, colocalization with SQSTM1/HDAC6 |
Proceedings of the National Academy of Sciences of the United States of America |
High |
32723828
|
| 2020 |
STUB1 promotes ubiquitination of BMAL1 via Lys-48-linked polyubiquitin chains, leading to its proteasomal degradation. Oxidative stress promotes STUB1 nuclear translocation and co-localization with BMAL1. STUB1-mediated BMAL1 degradation attenuates hydrogen peroxide-induced cell senescence. |
Affinity purification-MS, Co-IP, domain mapping, ubiquitination assay, proteasome inhibition, nuclear fractionation/localization, senescence-associated β-gal staining |
The Journal of biological chemistry |
High |
32041778
|
| 2022 |
STUB1 is an E3 ubiquitin ligase for the IFNγ receptor subunit IFNγ-R1 in complex with JAK1. STUB1 mediates ubiquitination-dependent proteasomal degradation of the IFNγ-R1/JAK1 complex through specific lysine residues IFNγ-R1K285 and JAK1K249, thereby suppressing tumor IFNγ signaling. |
Genome-wide CRISPR/Cas9 screen, Co-IP, ubiquitination assay, site-directed mutagenesis of ubiquitination sites, cytotoxic T-cell killing assay |
Nature communications |
High |
35395848
|
| 2020 |
Hsc70 mediates translocation of STUB1 onto oxidatively stressed peroxisomes, promoting their selective ubiquitination and autophagic degradation (pexophagy). Artificially targeting STUB1 to healthy peroxisomes is sufficient to trigger pexophagy. STUB1 ataxia patient mutants are defective in pexophagy induction. |
Live-cell imaging with optogenetic ROS induction, confocal microscopy, Stub1 targeting assay, patient mutant analysis, immunofluorescence |
Nature communications |
High |
33077711
|
| 2013 |
STUB1 constitutively interacts with the adaptor protein CARMA1, with interaction intensified by TCR stimulation. STUB1 ubiquitinates CARMA1 via Lys-27-linked chains, which is required for TCR-induced canonical NF-κB activation and IL-2 production. STUB1 knockdown abolishes endogenous CARMA1 ubiquitination and NF-κB activation downstream of TCR. |
Co-immunoprecipitation, RNAi knockdown, overexpression, ubiquitin linkage-specific analysis, NF-κB reporter assay, IL-2 measurement |
European journal of immunology |
Medium |
23322406
|
| 2014 |
Hsp70 and Hsp90 oppositely regulate CHIP/STUB1-mediated ubiquitination and degradation of Smad3. Overexpressed Hsp70 or Hsp90 inhibition (by geldanamycin) facilitates CHIP-induced Smad3 ubiquitination and degradation (enhancing TGF-β signaling sensitivity), while overexpressed Hsp90 antagonizes CHIP-mediated Smad3 ubiquitination (desensitizing TGF-β signaling). |
Co-immunoprecipitation, overexpression, pharmacological Hsp90 inhibition, ubiquitination assay, TGF-β signaling readouts |
Biochemical and biophysical research communications |
Medium |
24613385
|
| 2019 |
STUB1 ubiquitinates YAP1 at K280 via K48-linked polyubiquitination, promoting YAP1 proteasomal degradation and inhibiting cancer cell survival and chemoresistance in gastric cancer. |
Co-IP, ubiquitination assay, site-directed mutagenesis (K280), immunoblot, cell viability assays |
Cancer science |
Medium |
31393050
|
| 2017 |
STUB1 binds to RUNX1 and induces its ubiquitination and proteasomal degradation, primarily in the nucleus, and also promotes nuclear export of RUNX1. STUB1 similarly ubiquitinates the leukemogenic fusion RUNX1-RUNX1T1. Overexpression of STUB1 inhibits growth of myeloid leukemia cells harboring RUNX1-RUNX1T1. |
High-throughput binding assay, Co-IP, ubiquitination assay, immunofluorescence for nuclear/cytoplasmic localization, cell growth assays |
The Journal of biological chemistry |
Medium |
28536267
|
| 2023 |
CHIP/STUB1 binds ~10-fold more strongly to phosphorylated tau than unmodified tau via its TPR domain (partially distinct from canonical binding mode). Sub-stoichiometric CHIP strongly suppresses aggregation and seeding of phosphorylated tau and promotes rapid ubiquitination of phosphorylated (but not unmodified) tau in vitro. In cells, CHIP restricts seeding by phosphorylated tau. |
In vitro binding assay (panel of TPR-domain proteins), aggregation assay, in vitro ubiquitination assay, TPR domain mutagenesis, cell-based seeding assay |
Journal of molecular biology |
High |
37330289
|
| 2023 |
HSP90β inhibits STUB1-induced ubiquitination and degradation of YTHDF2 in the cytoplasm of hepatocellular carcinoma cells. The large and small middle domain of HSP90β is required for its interaction with both STUB1 and YTHDF2. STUB1 directly interacts with YTHDF2 to promote its ubiquitination-mediated proteasomal degradation. |
Co-immunoprecipitation, domain deletion mapping, ubiquitination assay, overexpression and knockdown, immunoblot |
Advanced science |
Medium |
37515378
|
| 2023 |
STUB1 is the E3 ubiquitin ligase for METTL14, directly interacting with it and mediating its ubiquitination at K148, K156, and K162 for proteasomal degradation. METTL3 competitively protects METTL14 from STUB1-mediated degradation via METTL3 amino acid regions 450-454 and 464-480, thereby maintaining m6A homeostasis. |
Co-IP, ubiquitination assay, site-directed mutagenesis of ubiquitination sites, domain mapping of METTL3, m6A quantification, immunoblot |
EMBO reports |
High |
36597993
|
| 2020 |
PDLIM5 interacts with SMAD3 (but not SMAD2) and competitively suppresses the interaction between SMAD3 and its E3 ubiquitin ligase STUB1, protecting SMAD3 from STUB1-mediated proteasomal degradation and maintaining TGF-β signaling in NSCLC cells. |
Co-IP, knockdown/overexpression, ubiquitination assay, immunoblot, rescue experiments |
The Journal of biological chemistry |
Medium |
32737199
|
| 2022 |
STUB1 promotes K63-linked non-degradative ubiquitination of aryl hydrocarbon receptor (AHR), facilitating Th17/Treg cell imbalance in rheumatoid arthritis. Specific ubiquitination sites on AHR were identified as responsible for STUB1-mediated K63 ubiquitination. |
Western blot, flow cytometry, siRNA knockdown, EROD enzymatic activity assay, ubiquitination assay with linkage-specific analysis |
Clinical and experimental immunology |
Medium |
35943876
|
| 2022 |
STUB1 promotes K48-linked polyubiquitination of AGO2 and Dicer (including aviDicer), targeting them for proteasomal degradation in a chaperone-dependent manner. STUB1 also induces degradation of AGO1, AGO3, and AGO4. STUB1 deficiency upregulates Dicer and AGO2, enhancing antiviral RNAi and inhibiting viral replication in mammalian cells and newborn mouse models. |
Co-IP, ubiquitination assay with K48-linkage analysis, overexpression/knockdown, in vivo newborn mouse model with virus-derived siRNA measurement |
Virologica Sinica |
Medium |
35533808
|
| 2017 |
CHIP/STUB1, when freed from chaperones during acute stress, docks on cellular membranes (phosphatidic acid and phosphatidylinositol-4-phosphate enhance association), performing a proteostasis sensor function. HSP70 and membranes compete for mutually exclusive binding to the TPR domain of CHIP. At new cellular locations, CHIP participates in Golgi apparatus fragmentation. |
In vitro reconstitution with liposomes, competition assay (HSP70 vs. membrane), cellular imaging of Golgi fragmentation, lipid binding assays |
eLife |
High |
29091030
|
| 2015 |
CHIP/STUB1 knockdown increases PTEN protein levels and decreases AKT/mTOR activity and ULK1 Ser757 phosphorylation, promoting autophagosome formation. However, CHIP knockdown also disturbs autophagic flux (impairs p62 substrate degradation) and increases susceptibility to autophagic cell death induced by bafilomycin A1. |
RNAi knockdown, immunoblot for autophagy pathway components (PTEN, AKT, mTOR, ULK1, p62), bafilomycin A1 treatment, cell death assay |
Neuroscience bulletin |
Medium |
26219223
|
| 2022 |
The E3 ubiquitin ligase STUB1 mediates ubiquitination and proteasomal degradation of Sox2 and Nanog via K48-linked chains, and Oct4 via K63-linked chains. STUB1 deficiency enhances somatic cell reprogramming and delays ESC differentiation, while enforced STUB1 expression triggers ESC differentiation. |
CRISPR-Cas9 KO library screen, Co-IP, K48/K63 linkage-specific ubiquitination assays, protein half-life measurement, reprogramming and differentiation assays |
Cell reports |
High |
35675767
|
| 2020 |
STUB1 deficiency leads to intracellular accumulation of protein aggregates and increased secretion of small extracellular vesicles (exosomes) enriched in ubiquitinated and/or undegraded proteins and oligomers. Oxidative stress augments sEV release in STUB1-depleted cells, indicating that STUB1 and exosomes cooperate to maintain proteostasis. |
STUB1 KO/knockdown, nanoparticle tracking analysis of sEVs, immunoblot for ubiquitinated proteins in sEVs, oxidative stress treatment |
PloS one |
Medium |
31613922
|
| 2023 |
Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated ubiquitination of GPX4 at site K191, leading to GPX4 degradation. STUB1 knockdown or GPX4 overexpression reverses imatinib-induced ferroptosis. |
Co-IP, ubiquitination assay with site-directed mutagenesis (K191), GPX4 knockdown/overexpression, ferroptosis markers (lipid ROS, Fe2+, GSH), in vivo xenograft |
Cell death & disease |
Medium |
38110356
|
| 2024 |
STUB1 mediates ubiquitination of NSUN2 at lysines K457 and K654, promoting NSUN2 proteasomal degradation during ferroptosis. NSUN2 degradation diminishes m5C methylation of Gpx4 mRNA 3' UTR, reducing GPX4 protein expression and promoting hepatocyte ferroptosis. |
Co-IP, ubiquitination assay with site-specific mutagenesis, m5C methylation assay, SECIS-SBP2 interaction assay, NSUN2 knockdown/overexpression, in vivo and in vitro ferroptosis models |
Cell reports |
High |
39453812
|
| 2023 |
STUB1 mediates ubiquitination and proteasomal degradation of GLUD1 at lysine K503, regulating glutamine catabolism in lung adenocarcinoma. Inhibition of K503 ubiquitination promotes proliferation and tumor growth. |
Co-IP, ubiquitination assay, site-directed mutagenesis (K503), cell proliferation assay, in vivo tumor growth |
iScience |
Medium |
37416474
|
| 2021 |
CHIP/STUB1 targets newly synthesized, HSP90/HSC70-associated ErbB2 for ubiquitin/proteasome-dependent degradation in the endoplasmic reticulum and Golgi, establishing a mechanism for negative regulation of cell surface ErbB2 levels in breast cancer cells. |
STUB1 knockdown and overexpression, proteasome inhibition, ER/Golgi fractionation, immunoblot, ErbB2 surface expression measurement |
Cancers |
Medium |
34439093
|
| 2014 |
CHIP/STUB1 directly interacts with eIF5A preferentially through its U-box domain, mediating eIF5A ubiquitination and proteasomal degradation. CHIP expression inversely correlates with eIF5A levels in colorectal cancers and in CHIP KO MEF cells. |
Proteomics identification, Co-IP, domain mapping (U-box), ubiquitination assay, CHIP KO MEF cells, immunoblot |
Cellular signalling |
Medium |
24509416
|
| 2020 |
STUB1 is targeted by the SUMO-interacting motif SIM3 of EBV EBNA1. The SIM3 motif mediates EBNA1's inhibitory effects on SUMO2-modified STUB1 and regulates SUMO2-mediated degradation of USP7. Hypoxic stress induces dissociation of EBNA1 from STUB1, increasing SUMO1 modification of STUB1 and KAP1 to promote lytic reactivation. |
Proteomic analysis, Co-IP, mutagenesis of SIM motifs, ubiquitination/SUMOylation assays, viral replication assays |
PLoS pathogens |
Medium |
32176739
|
| 2024 |
BCKDK phosphorylates STUB1 at S19, disrupting the STUB1-BCAT1 interaction and inhibiting STUB1-mediated ubiquitination and degradation of BCAT1, thereby stabilizing BCAT1 in glioblastoma. |
Co-IP, phosphorylation assay, ubiquitination assay, site-directed mutagenesis, in vivo and in vitro tumor models |
Cancer letters |
Medium |
38621458
|
| 2024 |
STUB1 is acetylated by KAT5 (lysine acetyltransferase 5), and KAT5 promotes STUB1 transcription via acetylation modulation. STUB1 then ubiquitinates and promotes degradation of LATS2, activating the YAP/β-catenin pathway and inhibiting NLRP3-mediated cardiomyocyte pyroptosis during myocardial ischemia-reperfusion injury. |
Acetylation assay, ubiquitination assay, KAT5/STUB1 overexpression/knockdown, LATS2 stability assay, pyroptosis markers, in vivo MIRI model |
Communications biology |
Medium |
38561411
|
| 2023 |
Salidroside increases STUB1 expression in Tregs and promotes STUB1-mediated degradation of Foxp3 in the nucleus, suppressing Treg function. Hsp70 is required for the colocalization of STUB1 and Foxp3 in the nucleus; Hsp70 inhibition reverses SAL-induced suppression of Foxp3 and disrupts the STUB1-Foxp3 colocalization. |
Flow cytometry, confocal laser microscopy for nuclear colocalization, Hsp70 inhibitor treatment, network pharmacology and molecular docking |
BMC cancer |
Low |
37528345
|
| 2020 |
Heterozygous missense variants in STUB1 (p.Ile53Thr and p.Thr37Leu) cause autosomal dominant ataxia. Neuropathological examination reveals selective Purkinje cell loss and aberrant STUB1 localization in distal Purkinje cell dendritic arbors (loss of normal somatodendritic polarization), linking STUB1 mislocalization to cerebellar pathogenesis. |
Exome sequencing, neuropathological examination, immunofluorescence localization of STUB1 in post-mortem brain tissue |
Neurology. Genetics |
Medium |
32211513
|
| 2023 |
STUB1 mediates ubiquitination of HOXB3, inhibiting its expression; loss of HOXB3 reduces PARK7 transcription (as HOXB3 binds PARK7 promoter), thereby promoting ferroptosis and suppressing paclitaxel resistance in ovarian cancer. |
Co-IP, dual luciferase reporter assay, ubiquitination assay, ChIP for HOXB3 binding to PARK7 promoter, in vivo xenograft |
Communications biology |
Medium |
39501077
|
| 2023 |
STUB1 ubiquitinates and promotes degradation of SMYD2 in glioma cells treated with cisplatin; STUB1 knockdown reverses cisplatin-induced SMYD2 degradation and partially restores cell function. |
UbiBrowser prediction confirmed by knockdown, ubiquitination assay, Co-IP, cell functional assays |
Journal of molecular neuroscience |
Low |
35939202
|
| 2023 |
Allosteric inhibition of HSP70 (by JG98/JG231) promotes STUB1 nuclear translocation to bind and degrade AR-V7 in enzalutamide-resistant prostate cancer cells. STUB1 knockdown diminishes the anticancer effects and partially restores AR-V7 levels, indicating that HSP70/STUB1 machinery regulates AR/AR-V7 protein stability. |
STUB1 knockdown, nuclear fractionation/localization, Co-IP, immunoblot, cell growth assays, in vivo xenograft |
Pharmacological research |
Medium |
36773708
|
| 2021 |
TRIM6 interacts with STUB1 and promotes ubiquitination-mediated proteasomal degradation of STUB1, leading to increased YAP1 protein levels and enhanced breast cancer progression. |
Co-IP, ubiquitination assay, TRIM6 overexpression/knockdown, YAP1 protein level measurements, in vitro and in vivo cancer growth assays |
European journal of histochemistry |
Medium |
33728863
|